Questions fly over trading in Guidant stock: SEC among regulators scrutinizing share sales
A Securities and Exchange Commission investigation and a fresh batch of lawsuits are prompting more questions about whether anyone used inside information to unload Guidant Corp. shares before the company’s stock began to slide. The Indianapolis-based medical-device maker, which is riding a wave of bad news dating to last spring, disclosed Nov. 7 that the SEC launched “a formal inquiry” into certain product disclosures and stock trading. That means the commission has questions about insider trading, and it’s armed with…